Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 03, 2015 7:33 PM ET

Biotechnology

Company Overview of Syndax Pharmaceuticals, Inc.

Executive Profile

Ronald M. Evans Ph.D.

Co-Founder and Advisor, Syndax Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
----

Background

Mr. Ronald M. Evans, Ph.D., co-founded Syndax Pharmaceuticals, Inc. in 2005 and serves as its Advisor. Dr. Evans serves as a Professor in the Gene Expression Laboratory and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California. Dr. Evans is a Co-founder of several companies including Ligand Pharmaceuticals, X-Ceptor Pharmaceuticals, and Xenopharm, while serving on the scientific advisory board ...

Corporate Headquarters

400 Totten Pond Road
Waltham, Massachusetts 02451

United States

Phone: 781-419-1400
Fax: 781-419-1420

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University of California
BA
University of California
PhD
University of California-Los Angeles
BA
University of California-Los Angeles

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.